The ethics of underpowered clinical trials
Lilford, R.J.
JAMA 288(17): 2118-9; Author Reply 2119
2002
ISSN/ISBN: 0098-7484 PMID: 12413364 Document Number: 544119
Document emailed within 1 workday
Related Documents
Weigmann, K. 2015: The ethics of global clinical trials: in developing countries, participation in clinical trials is sometimes the only way to access medical treatment. what should be done to avoid exploitation of disadvantaged populations? Embo Reports 16(5): 566-570Lore, W. 1985: Clinical trials and medical ethics East African Medical Journal 62(1): 1-2
Whalan, D.J. 1975: The ethics and morality of clinical trials in man Medical Journal of Australia 1(16): 491-494
Homb, T. 1993: Ethics and mathematics in clinical trials Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 113(7): 867-868
Wilde, H.; Phaosavasdi, S.; Pruksapong, C.; Tannirandorn, Y.; Taneepanichskul, S. 1999: Ethics of using controls and placebo in clinical trials Journal of the Medical Association of Thailand 82(6): 632-635
Del-Ré, R. 1995: Ethics committees and clinical trials: it's more than change of name Medicina Clinica 105(15): 580-582
Béréterbide, F.; Hirsch, F. 2008: Clinical trials in developing countries: who should define ethics? Bulletin de la Societe de Pathologie Exotique 101(2): 102-105
McCormick, M.C. 1995: Ethics of consent for babies in randomised clinical trials Lancet 345(8961): 1370-1371
Greco, D.B. 1999: Clinical trials in "developing" countries: the fallacy of urgency or ethics vs. economics Bulletin of Medical Ethics No. 150: 33-34
1984: Ethics debate heats up as gene therapy moves toward clinical trials Medical World News 25(21): 34 36
Sedivý, J.; Setka, J.; Rusek, J. 1992: The role of ethics committees in evaluating the ethical aspects of clinical drug trials Casopis Lekaru Ceskych 131(17): 539-540
Lund, L.H. 2008: Ethics committees in USA--background and development. Responsible conductors of clinical trials required for risk minimization Lakartidningen 105(1-2): 42-44
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Braddock, C.H.; Tonelli, M.R. 2001: Too much ethics, not enough medicine: clarifying the role of clinical expertise for the clinical ethics consultant Journal of Clinical Ethics 12(1): 24-30
Dancey, J.E.; Schoenfeldt, M. 2003: Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor Oncology 17(6): 819; 826
Davis, T.; Gore-Langton, R.E.; Cheson, B.D. 2000: Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab Oncology 14(10): 1437; 1440-1443
Baldini, C.; Delle Sedie, A.; Bombardieri, S. 2005: From clinical trials to the bedside: how can we treat patients with rheumatoid arthritis and concurrent morbidities who are generally excluded from randomised controlled clinical trials? Clinical and Experimental Rheumatology 23(6): 893-904
Saxman, S.B.; West, P.J.; Cheson, B.D. 2001: Clinical trials referral resource. Current clinical trials in small-cell lung cancer Oncology 15(3): 318-319; 323
Trimble, E.L.; Rowland, J.; Varricchio, C.; Gore-Langton, R.E. 2001: Clinical trials referral resource. Health-related quality of life in cancer clinical trials Oncology 15(5): 601